FCM
CYNA

Farallon Capital Management’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

Farallon Capital Management’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-505,000
Closed -$20.3M – 87
2016
Q3 		$20.3M Buy
+505,000
New +$12.5M 0.3% 42

Farallon Capital Management's CYNA Position: Q4 2016 in Review

Farallon Capital Management sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 505,000 shares — an estimated $20.3M sold.

Farallon Capital Management first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $20.3M in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • Farallon Capital Management reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • Farallon Capital Management sold 505,000 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $20.3M.
  • Farallon Capital Management first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
  • Farallon Capital Management's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $20.3M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on Farallon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.